Tag Archives: Bariatric Surgery

Bariatric Surgery Reduces Microvascular Complications of Type 2 Diabetes

bariatric surgery, Steve Parker MD

Band Gastric Bypass Surgery (not the only type of gastric bypass): very successful at “curing” T2 diabetes if you survive the operation

Folks with T2 diabetes who undergo weight-loss surgery (bariatric surgery) often see a reversal or remission of their diabetes. The reversal doesn’t always last.

In either case, bariatric surgery does seem to reduce the risk if microvascular complications, namely retinopathy (eye disease), neuropathy (nerve pain or numbness), and nephropathy (kidney disease).

The conclusion of a recent study:

“Our results indicate that remission of type 2 diabetes after bariatric surgery confers benefits for risk of incident microvascular disease even if patients eventually experience a relapse of their type 2 diabetes. This provides support for a legacy effect of bariatric surgery, where even a transient period of surgically induced type 2 diabetes remission is associated with lower long-term microvascular disease risk.”

Source: Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery | Diabetes Care

Comments Off on Bariatric Surgery Reduces Microvascular Complications of Type 2 Diabetes

Filed under Diabetes Complications

If You’re Having Bariatric Surgery to Treat Your Type 2 Diabetes, You May Want RYGB Instead of LAGB

MP900308894[1]

An article at Diabetes Care suggests that insulin-treated T2 diabetics getting bariatric surgery were almost twice as likely to get off insulin if they had roux-en-Y gastric bypass rather than laparoscopic adjustable gastric banding. The former procedure is also generally more effective for weight loss.

If you think bariatric surgery is a sure-fire cure for type 2 diabetes, it’s not.

Steve Parker, M.D.

1 Comment

Filed under Overweight and Obesity

In T2 Diabetes, Which Comes First: High Insulin Levels or Insulin Resistance?

pancreas, liver, insulin, woman, teacher, books, diabetes, cause of diabetes

I couldn’t find a decent picture of a liver or pancreas, so this will have to do….

Excessive insulin output by the pancreas (hyperinsulinemia) is the underlying cause of type 2 diabetes, according to a hypothesis from Walter Pories, M.D., and G. Lynis Dohm, Ph.D.  The cause of the hyperinsulinemia is a yet-to-be-identified “diabetogenic signal” to the pancreas from the gastrointestinal tract.

This is pretty sciencey, so you’re excused if you stop reading now.  You probably should.

They base their hypothesis on the well-known cure or remission of many cases of type 2 diabetes quite soon after roux-en-y gastric bypass surgery (RYGB) done for weight loss.  (Recent data indicate that six years after surgery, the diabetes has recurred in about a third of cases.)  Elevated fasting insulin levels return to normal within a week of RYGB and remain normal for at least three months.  Also soon after surgery, the pancreas recovers the ability to respond to a meal with an appropriate insulin spike.  Remission or cure of type 2 diabetes after RYGB is independent of changes in weight, insulin sensitivity, or free fatty acids.

Bariatric surgery provides us with a “natural” experiment into the mechanisms behind type 2 diabetes.

The primary anatomic change with RYGB is exclusion of food from a portion of the gastrointestinal tract, which must send a signal to the pancreas resulting in lower insulin levels, according to Pories and Dohm.

Why would fasting blood sugar levels fall so soon after RYGB?  To understand, you have to know that fasting glucose levels primarily reflect glucose production by the liver (gluconeogenesis).  It’s regulated by insulin and other hormones.  Insulin generally suppresses gluconeogenesis.  The lower insulin levels after surgery should raise fasting glucose levels then, don’t you think?  But that’s not the case.

Pories and Dohm surmise that correction of hyperinsulinemia after surgery leads to fewer glucose building blocks (pyruvate, alanine, and especially lactate) delivered from muscles to the liver for glucose production.  Their explanation involves an upregulated Cori cycle, etc.  It’s pretty boring and difficult to follow unless you’re a biochemist.

The theory we’re talking about is contrary to the leading theory that insulin resistance causes hyperinsulinemia.  Our guys are suggesting it’s the other way around: hyperinsulinemia causes insulin resistance.  It’s a chicken or the egg sort of thing.

If they’re right, Pories and Dohm say we need to rethink the idea of treating type 2 diabetes with insulin except in the very late stages when there may be no alternative.  (I would add my concern about using insulin secretagogues (e.g., sulfonylureas) in that case also.)  If high insulin levels are the culprit, you don’t want to add to them.

We’d also need to figure out what is the source of the “diabetogenic signal” from the gastrointestinal tract to the pancreas that causes hyperinsulinemia.  A number of stomach and intestinal hormones can affect insulin production by the pancreas; these were not mentioned specifically by Pories and Dohm.  Examples are GIP and GLP-1 (glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1).

Keep these ideas in mind when you come across someone who’s cocksure that they know the cause of type 2 diabetes.

Steve Parker, M.D.

Reference:  Pories, Walter and Dohm, G. Lynis.  Diabetes: Have we got it all wrong?  Hyperinsulinism as the culprit: surgery provides the evidence.  Diabetes Care, 2012, vol. 35, p. 2438-2442.

8 Comments

Filed under Causes of Diabetes

A Chance to Cut is a Chance to Cure

"Has anybody seen my pen?"

"Has anybody seen my pen?"

Gastric bypass is the most common bariatric surgery in the U.S.  The odds of dying from that procedure are roughly 1 in 200.  Thousands of people sign on the dotted line for it every year.  Why do they take that risk?

A recent study out of Sweden shows that people who undergo various bariatric surgeries reduce their risk of death over the next 11 years by 25%.

In the Swedish Obese Subjects Study, 2010 subjects underwent bariatric surgery and 2037 received conventional treatment.  Overall mortality was recorded over the next 11 years.  Only three of the subjects were lost to follow-up (unknown whether alive or not).  The average body mass index (BMI) for all subjects was 41.

Out of the conventional treatment group, 126 died.  In the surgery group, only 101 died.  Average weight change in the conventional treatment group was up or down only 2%.  People in the surgery group were given one of three operations: gastric bypass, vertical-banded gastroplasty, or banding.  After 10 years, average weight loss of the groups was 25%, 16%, and 14%, respectively.

Over the course of 11 years, people in the surgery group had 25% less chance of dying when compared to the conventional treatment group.  The most common causes of death were heart attacks and cancer.

Even better results were found back in the U.S.  Researchers in Utah looked at mortality rates of 7925 patients who had undergone gastric bypass surgery between 1984 and 2002.  They compared death rates to a control group (also 7925 people) of obese people who applied for driver’s licenses.  Subjects were matched for sex, body mass index, and age.  Average BMI of the surgical group was 45.

Over the course of seven years, there were 321 deaths in the control group and 213 in the surgery group.  Deaths from any cause were reduced by 40% in the surgery group, compare to the control group.  Surgery patients had less death from cardiovascular disease, diabetes, and cancer.

Surgery is definitely a roll of the dice.  Now you know why people play the game.

Steve Parker, M.D.

References:

Sjostrom, Lars, et al.  Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects.  New England Journal of Medicine, 357 (2007):  741-752.

Adams, Ted, et al.  Long-Term Mortality after Gastric Bypass Surgery.  New England Journal of Medicine, 357 (2007): 753-761. 

6 Comments

Filed under Bariatric Surgery, Overweight and Obesity